Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fleckenstein

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicityJ Paul Hansen, Evan L Riddle, Verónica Sandoval, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2010
Effect of methamphetamine self-administration on neurotensin systems of the basal gangliaPaul S Frankel, Amanda J Hoonakker, Mario E Alburges, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 14, 2018
Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorderKaren Curtin, Annette E Fleckenstein, Brooks R Keeshin, et al.
European Journal of Pharmacology|January 24, 2007
Persistence of tolerance to methamphetamine-induced monoamine deficitsJonathan P Danaceau, Cassandra E Deering, Jayme E Day, et al.
European Journal of Pharmacology|November 27, 2002
Inhibitory effect of reserpine on dopamine transporter functionRyan R Metzger, Jeffrey M Brown, Verónica Sandoval, et al.
European Journal of Pharmacology|July 5, 2008
Differential regional effects of methamphetamine on dopamine transportPei-Wen Chu, Kristi S Seferian, Elisabeth Birdsall, et al.
European Journal of Pharmacology|March 28, 2009
Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatmentJarom E Hanson, Elisabeth Birdsall, Kristi S Seferian, et al.
Neuropharmacology|August 7, 2013
Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotineS Charntikov, N Swalve, S Pittenger, et al.
Drug and Alcohol Dependence|June 1, 2012
Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrationsLisa M McFadden, Madison M Hunt, Paula L Vieira-Brock, et al.
JAMA Internal Medicine|November 27, 2023
Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical TrialKristine Yaffe, Eric Vittinghoff, Sascha Dublin, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicityJ Paul Hansen, Evan L Riddle, Verónica Sandoval, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2010
Effect of methamphetamine self-administration on neurotensin systems of the basal gangliaPaul S Frankel, Amanda J Hoonakker, Mario E Alburges, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 14, 2018
Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorderKaren Curtin, Annette E Fleckenstein, Brooks R Keeshin, et al.
European Journal of Pharmacology|January 24, 2007
Persistence of tolerance to methamphetamine-induced monoamine deficitsJonathan P Danaceau, Cassandra E Deering, Jayme E Day, et al.
European Journal of Pharmacology|November 27, 2002
Inhibitory effect of reserpine on dopamine transporter functionRyan R Metzger, Jeffrey M Brown, Verónica Sandoval, et al.
European Journal of Pharmacology|July 5, 2008
Differential regional effects of methamphetamine on dopamine transportPei-Wen Chu, Kristi S Seferian, Elisabeth Birdsall, et al.
European Journal of Pharmacology|March 28, 2009
Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatmentJarom E Hanson, Elisabeth Birdsall, Kristi S Seferian, et al.
Neuropharmacology|August 7, 2013
Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotineS Charntikov, N Swalve, S Pittenger, et al.
Drug and Alcohol Dependence|June 1, 2012
Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrationsLisa M McFadden, Madison M Hunt, Paula L Vieira-Brock, et al.
JAMA Internal Medicine|November 27, 2023
Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical TrialKristine Yaffe, Eric Vittinghoff, Sascha Dublin, et al.
Pageof 14